Register
Login
Global drug development consultancy Boyds has partnered with BioPharma Connections in the company’s latest move to continue its growth in the US.
Patients to benefit from game-changing full-body scans to provide a richer picture of human health for clinical research.
OBN is pleased to announce the appointment of a new Chief Executive Officer. Industry expert, Stuart Rose, will step into the role following the retirement of long-standing CEO, John Harris.